UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects

NCT06272253 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
250
Enrollment
OTHER_GOV
Sponsor class

Conditions

Interventions

Sponsor

Dr. Soetomo General Hospital

Collaborators